The term "litigation loans" is commonly used by companies searching for capital to pursue a lawsuit. In practice, most sophisticated commercial funding structures are not traditional loans. They are structured as non-recourse litigation funding arrangements.
Understanding this distinction is especially important in high value commercial disputes such as trade secret misappropriation, intellectual property litigation, and complex breach of contract matters. When structured properly, litigation funding is not debt. It is risk capital deployed to support strong, economically viable claims.
What people mean when they search for litigation loans
When businesses search for litigation loans, they are typically seeking financial support to cover substantial litigation costs, including:
- Attorney fees
- Expert witness costs
- Electronic discovery and forensic analysis
- Court fees and related expenses
In large commercial cases, particularly trade secret lawsuits, these expenses can reach millions of dollars over several years. For growth stage or innovation driven companies, self funding prolonged litigation may strain operations or divert capital from strategic priorities.
As a result, the phrase "litigation loans" has become shorthand for accessing outside capital to enforce legal rights without disrupting the business.
The key difference between litigation loans and litigation funding
Traditional loans require repayment regardless of outcome. Commercial litigation funding, by contrast, is almost always structured as non-recourse capital.
Under a non-recourse structure:
- The funder receives an agreed portion of any recovery if the case succeeds
- If there is no recovery, the plaintiff generally owes nothing
- The arrangement is not structured as conventional debt
This distinction is critical in trade secret litigation and other high value disputes where outcomes are uncertain and timelines extended. Non-recourse litigation funding shifts financial risk away from the company while preserving operational liquidity.
When companies typically consider litigation funding
Companies most often explore litigation funding in matters involving:
Trade secret misappropriation by a competitor
Employee theft of confidential information
Breach of nondisclosure or noncompete agreements
High value intellectual property disputes
Claims against well capitalized defendants
In many trade secret cases, projected damages may be significant, but the upfront cost of enforcement creates hesitation. Access to non-recourse funding allows companies to pursue meritorious claims without compromising day to day operations.
Increasingly, sophisticated plaintiffs treat litigation funding as a strategic capital allocation tool rather than a last resort.
How litigation funding companies evaluate cases
Although the phrase "litigation loans" suggests a simple lending decision, the evaluation process is rigorous and investment driven. Litigation funding companies conduct detailed due diligence before deploying capital.
Core evaluation criteria typically include:
Strength of liability under applicable law such as the Defend Trade Secrets Act or state Uniform Trade Secrets Act statutes
- Quality and preservation of evidence
- A credible and quantified damages model
- Defendant solvency and collectability
- A realistic litigation budget and projected timeline
In trade secret disputes, thorough documentation of reasonable secrecy measures, forensic evidence of misappropriation, and disciplined economic modeling materially improve funding prospects.
Strategic benefits of litigation funding in high value cases
When structured appropriately, litigation funding provides meaningful strategic advantages:
- Preservation of operating capital and balance sheet strength
- Transfer of downside litigation risk
- Enhanced leverage in settlement discussions
- Alignment of enforcement decisions with economic merit rather than liquidity constraints
- The ability to level the playing field against larger or better resourced opponents
For companies facing stolen trade secrets or competitive misconduct, access to non-recourse capital can determine whether enforcement is viable.
Is litigation funding right for your dispute
Not every matter qualifies. Litigation funding companies are selective and typically approve only cases with strong liability, meaningful damages potential, and realistic recovery prospects against a solvent defendant.
However, when a high value claim such as trade secret misappropriation involves protectable confidential information, clear evidence of misuse, and substantial economic harm, litigation funding can provide a disciplined and strategically sound path forward.
Conclusion
If your company is exploring litigation loans or non-recourse litigation funding for a trade secret lawsuit or other high value commercial dispute, early evaluation is essential. Careful preparation on liability, evidence preservation, and damages modeling materially improves funding outcomes.
If you would like to assess whether your claim meets institutional funding criteria, we can provide a confidential evaluation of liability strength, damages potential, and overall investability.
This information is general in nature and not legal or investment advice. Laws vary by jurisdiction. Consult qualified counsel and advisors for advice specific to your situation.